Menu
← Oncology Approval Tracker
FDA DECISION ·
Methotrexate Injection
methotrexate sodium · Hospira
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
FDA broadened injectable methotrexate’s lymphoma labeling to include all non-Hodgkin lymphoma histologic subsets. The same supplement revised the oncology label and dosing instructions.
LAMPGEN ANALYSIS
Why it matters
This changes the labeled scope of an established injectable oncology drug and modernizes older indication language.
What research teams should watch
Use the revised label to verify histology, approved route and regimen-specific instructions.
PRIMARY RECORDS